/us/usc/t21/s16 Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
/us/usc/t21/s17 Penalty for sale or introduction of falsely labeled dairy or food products; venue
/us/usc/t21/s18 Suspension of importation of adulterated articles
/us/usc/t21/s20 Apples in interstate commerce; standard grades
/us/usc/t21/s21 Branding grades on barrels of apples
/us/usc/t21/s22 Barrels misbranded
/us/usc/t21/s23 Penalties
/us/usc/t21/s25 Oleomargarine, butterine, or imitation butter or cheese transported into a State subject to its police powers
/us/usc/t21/s61 Definitions
/us/usc/t21/s62 Manufacture, shipment, or delivery for shipment in interstate or foreign commerce prohibited
/us/usc/t21/s63 Penalties; acts of agents deemed acts of principals
/us/usc/t21/s64 Regulations for enforcement
/us/usc/t21/s101 Suspension of importation of all animals
/us/usc/t21/s113a Establishment of research laboratories for foot-and-mouth disease and other animal diseases; research contracts; employment of technicians and scientists; appropriations
/us/usc/t21/s114i Pseudorabies eradication
/us/usc/t21/s136 Additional inspection services
/us/usc/t21/s136a Collection of fees for inspection services
/us/usc/t21/s141 Prohibition of importation without permit
/us/usc/t21/s142 Milk or cream when unfit for importation
/us/usc/t21/s143 Inspection; certified statement in lieu thereof; waiver of requirements of section 142; regulations; suspension and revocation of permits
/us/usc/t21/s144 Unlawful receiving of imported milk or cream
/us/usc/t21/s145 Penalties
/us/usc/t21/s146 Authorization of appropriations
/us/usc/t21/s147 Repeal of inconsistent laws
/us/usc/t21/s148 Powers of State with respect to milk or cream lawfully imported
/us/usc/t21/s149 Definitions
/us/usc/t21/s151 Preparation and sale of worthless or harmful products for domestic animals prohibited; preparation to be in compliance with rules at licensed establishments
/us/usc/t21/s152 Importation regulated and prohibited
/us/usc/t21/s153 Inspection of imports; denial of entry and destruction
/us/usc/t21/s154 Regulations for preparation and sale; licenses
/us/usc/t21/s154a Special licenses for special circumstances; expedited procedure; conditions; exemptions; criteria
/us/usc/t21/s155 Permits for importation
/us/usc/t21/s156 Licenses conditioned on permitting inspection; suspension of licenses
/us/usc/t21/s157 Inspection
/us/usc/t21/s158 Offenses; punishment
/us/usc/t21/s159 Enforcement; penalties applicable; Congressional findings
/us/usc/t21/s201 Doing business without a license unlawful; employment of Chinese subjects
/us/usc/t21/s202 Certain classes of persons and corporations excepted; insecticides
/us/usc/t21/s203 Application for license; requirements; qualifications for license
/us/usc/t21/s204 Issuance of license
/us/usc/t21/s205 Display of license in pharmacy
/us/usc/t21/s206 Revocation of license
/us/usc/t21/s207 Restrictions on sales; written orders or prescriptions
/us/usc/t21/s208 Certain preparations and sales excepted
/us/usc/t21/s209 Poisons; book entry of sale; labels
/us/usc/t21/s210 Pharmacist; unauthorized use of title
/us/usc/t21/s211 Preservation of originals of prescriptions compounded and copies thereof; inspection of prescriptions by consular officers; marking containers of drugs
/us/usc/t21/s212 Offenses; punishment; duty to enforce provisions
/us/usc/t21/s213 Fraudulent representations to evade or defeat restrictions
/us/usc/t21/s214 Previous laws unaffected
/us/usc/t21/s215 “Consul” defined
/us/usc/t21/s301 Short title
/us/usc/t21/s321 Definitions; generally
/us/usc/t21/s321a “Butter” defined
/us/usc/t21/s321b “Package” defined
/us/usc/t21/s321c Nonfat dry milk; “milk” defined
/us/usc/t21/s321d Market names for catfish and ginseng
/us/usc/t21/s331 Prohibited acts
/us/usc/t21/s332 Injunction proceedings
/us/usc/t21/s333 Penalties
/us/usc/t21/s334 Seizure
/us/usc/t21/s335 Hearing before report of criminal violation
/us/usc/t21/s335a Debarment, temporary denial of approval, and suspension
/us/usc/t21/s335b Civil penalties
/us/usc/t21/s335c Authority to withdraw approval of abbreviated drug applications
/us/usc/t21/s336 Report of minor violations
/us/usc/t21/s337 Proceedings in name of United States; provision as to subpoenas
/us/usc/t21/s337a Extraterritorial jurisdiction
/us/usc/t21/s341 Definitions and standards for food
/us/usc/t21/s342 Adulterated food
/us/usc/t21/s343 Misbranded food
/us/usc/t21/s343-1 National uniform nutrition labeling
/us/usc/t21/s343-2 Dietary supplement labeling exemptions
/us/usc/t21/s343-3 Disclosure
/us/usc/t21/s344 Emergency permit control
/us/usc/t21/s345 Regulations making exemptions
/us/usc/t21/s346 Tolerances for poisonous or deleterious substances in food; regulations
/us/usc/t21/s346a Tolerances and exemptions for pesticide chemical residues
/us/usc/t21/s346b Authorization of appropriations
/us/usc/t21/s347 Intrastate sales of colored oleomargarine
/us/usc/t21/s347a Congressional declaration of policy regarding oleomargarine sales
/us/usc/t21/s347b Contravention of State laws
/us/usc/t21/s348 Food additives
/us/usc/t21/s349 Bottled drinking water standards; publication in Federal Register
/us/usc/t21/s350 Vitamins and minerals
/us/usc/t21/s350a Infant formulas
/us/usc/t21/s350b New dietary ingredients
/us/usc/t21/s350c Maintenance and inspection of records
/us/usc/t21/s350d Registration of food facilities
/us/usc/t21/s350e Sanitary transportation practices
/us/usc/t21/s350f Reportable food registry
/us/usc/t21/s350g Hazard analysis and risk-based preventive controls
/us/usc/t21/s350h Standards for produce safety
/us/usc/t21/s350i Protection against intentional adulteration
/us/usc/t21/s350j Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report
/us/usc/t21/s350k Laboratory accreditation for analyses of foods
/us/usc/t21/s350l Mandatory recall authority
/us/usc/t21/s350l-1 Annual report to Congress
/us/usc/t21/s351 Adulterated drugs and devices
/us/usc/t21/s352 Misbranded drugs and devices
/us/usc/t21/s353 Exemptions and consideration for certain drugs, devices, and biological products
/us/usc/t21/s353a Pharmacy compounding
/us/usc/t21/s353a-1 Enhanced communication
/us/usc/t21/s353b Outsourcing facilities
/us/usc/t21/s353c Prereview of television advertisements
/us/usc/t21/s353d Process to update labeling for certain generic drugs
/us/usc/t21/s354 Veterinary feed directive drugs
/us/usc/t21/s355 New drugs
/us/usc/t21/s355-1 Risk evaluation and mitigation strategies
/us/usc/t21/s355-2 Actions for delays of generic drugs and biosimilar biological products
/us/usc/t21/s355a Pediatric studies of drugs
/us/usc/t21/s355b Adverse-event reporting
/us/usc/t21/s355c Research into pediatric uses for drugs and biological products
/us/usc/t21/s355c-1 Report
/us/usc/t21/s355d Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
/us/usc/t21/s355e Pharmaceutical security
/us/usc/t21/s355f Extension of exclusivity period for new qualified infectious disease products
/us/usc/t21/s355g Utilizing real world evidence
/us/usc/t21/s355h Regulation of certain nonprescription drugs that are marketed without an approved drug application
/us/usc/t21/s356 Expedited approval of drugs for serious or life-threatening diseases or conditions
/us/usc/t21/s356-1 Accelerated approval of priority countermeasures
/us/usc/t21/s356a Manufacturing changes
/us/usc/t21/s356b Reports of postmarketing studies
/us/usc/t21/s356c Discontinuance or interruption in the production of life-saving drugs
/us/usc/t21/s356c-1 Annual reporting on drug shortages
/us/usc/t21/s356d Coordination; task force and strategic plan
/us/usc/t21/s356e Drug shortage list
/us/usc/t21/s356f Hospital repackaging of drugs in shortage
/us/usc/t21/s356g Standards for regenerative medicine and regenerative advanced therapies
/us/usc/t21/s356h Competitive generic therapies
/us/usc/t21/s356i Prompt reports of marketing status
/us/usc/t21/s356j Discontinuance or interruption in the production of medical devices
/us/usc/t21/s357 Qualification of drug development tools
/us/usc/t21/s358 Authority to designate official names
/us/usc/t21/s359 Nonapplicability of subchapter to cosmetics
/us/usc/t21/s360 Registration of producers of drugs or devices
/us/usc/t21/s360a Clinical trial guidance for antibiotic drugs
/us/usc/t21/s360aa Recommendations for investigations of drugs for rare diseases or conditions
/us/usc/t21/s360a-1 Clinical trials
/us/usc/t21/s360a-2 Susceptibility test interpretive criteria for microorganisms
/us/usc/t21/s360b New animal drugs
/us/usc/t21/s360bbb-0 Expanded access policy required for investigational drugs
/us/usc/t21/s360bb Designation of drugs for rare diseases or conditions
/us/usc/t21/s360bbb Expanded access to unapproved therapies and diagnostics
/us/usc/t21/s360bbb-0a Investigational drugs for use by eligible patients
/us/usc/t21/s360b-1 Priority zoonotic animal drugs
/us/usc/t21/s360bbb-1 Dispute resolution
/us/usc/t21/s360bbb-2 Classification of products
/us/usc/t21/s360bbb-3 Authorization for medical products for use in emergencies
/us/usc/t21/s360bbb-3a Emergency use of medical products
/us/usc/t21/s360bbb-3b Products held for emergency use
/us/usc/t21/s360bbb-3c Expedited development and review of medical products for emergency uses
/us/usc/t21/s360bbb-4 Countermeasure development, review, and technical assistance
/us/usc/t21/s360bbb-4a Priority review to encourage treatments for agents that present national security threats
/us/usc/t21/s360bbb-4b Medical countermeasure master files
/us/usc/t21/s360bbb-5 Critical Path Public-Private Partnerships
/us/usc/t21/s360bbb-6 Risk communication
/us/usc/t21/s360bbb-7 Notification
/us/usc/t21/s360bbb-8 Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
/us/usc/t21/s360bbb-8a Optimizing global clinical trials
/us/usc/t21/s360bbb-8b Use of clinical investigation data from outside the United States
/us/usc/t21/s360bbb-8c Patient participation in medical product discussion
/us/usc/t21/s360bbb-8d Notification, nondistribution, and recall of controlled substances
/us/usc/t21/s360c Classification of devices intended for human use
/us/usc/t21/s360c-1 Reporting
/us/usc/t21/s360d Performance standards
/us/usc/t21/s360dd Open protocols for investigations of drugs for rare diseases or conditions
/us/usc/t21/s360ddd Definitions
/us/usc/t21/s360ddd-1 Regulation of medical gases
/us/usc/t21/s360ddd-2 Inapplicability of drug fees to designated medical gases
/us/usc/t21/s360eee Definitions
/us/usc/t21/s360ee Grants and contracts for development of drugs for rare diseases and conditions
/us/usc/t21/s360e Premarket approval
/us/usc/t21/s360eee-1 Requirements
/us/usc/t21/s360e-1 Pediatric uses of devices
/us/usc/t21/s360eee-2 National standards for prescription drug wholesale distributors
/us/usc/t21/s360eee-3 National standards for third-party logistics providers
/us/usc/t21/s360e-3 Breakthrough devices
/us/usc/t21/s360eee-4 Uniform national policy
/us/usc/t21/s360ff Priority review to encourage treatments for rare pediatric diseases
/us/usc/t21/s360f Banned devices
/us/usc/t21/s360fff Definitions
/us/usc/t21/s360fff-1 Submission of requests
/us/usc/t21/s360ff-1 Targeted drugs for rare diseases
/us/usc/t21/s360fff-2 Eligibility determinations; data submission; filing
/us/usc/t21/s360fff-3 GRASE determination
/us/usc/t21/s360fff-4 Guidance; other provisions
/us/usc/t21/s360fff-6 Non-sunscreen time and extent applications
/us/usc/t21/s360fff-7 Report
/us/usc/t21/s360fff-8 Sunset
/us/usc/t21/s360g Judicial review
/us/usc/t21/s360g-1 Agency documentation and review of significant decisions regarding devices
/us/usc/t21/s360hh Definitions
/us/usc/t21/s360h Notification and other remedies
/us/usc/t21/s360h-1 Program to improve the device recall system
/us/usc/t21/s360i Records and reports on devices
/us/usc/t21/s360jj Studies by Secretary
/us/usc/t21/s360j General provisions respecting control of devices intended for human use
/us/usc/t21/s360kk Performance standards for electronic products
/us/usc/t21/s360ii Program of control
/us/usc/t21/s360k State and local requirements respecting devices
/us/usc/t21/s360ll Notification of defects in and repair or replacement of electronic products
/us/usc/t21/s360l Postmarket surveillance
/us/usc/t21/s360m Accredited persons
/us/usc/t21/s360n Priority review to encourage treatments for tropical diseases
/us/usc/t21/s360nn Inspection, records, and reports
/us/usc/t21/s360n-1 Priority review for qualified infectious disease products
/us/usc/t21/s360oo Prohibited acts
/us/usc/t21/s360pp Enforcement
/us/usc/t21/s360rr Federal-State cooperation
/us/usc/t21/s360ss State standards
/us/usc/t21/s360cc Protection for drugs for rare diseases or conditions
/us/usc/t21/s360ccc Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
/us/usc/t21/s360ccc-1 Index of legally marketed unapproved new animal drugs for minor species
/us/usc/t21/s360ccc-2 Designated new animal drugs for minor use or minor species
/us/usc/t21/s361 Adulterated cosmetics
/us/usc/t21/s362 Misbranded cosmetics
/us/usc/t21/s360mm Imports
/us/usc/t21/s363 Regulations making exemptions
/us/usc/t21/s371 Regulations and hearings
/us/usc/t21/s372 Examinations and investigations
/us/usc/t21/s373 Records
/us/usc/t21/s374 Inspection
/us/usc/t21/s374a Inspections relating to food allergens
/us/usc/t21/s375 Publicity
/us/usc/t21/s376 Examination of sea food on request of packer; marking food with results; fees; penalties
/us/usc/t21/s377 Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
/us/usc/t21/s378 Advertising of foods
/us/usc/t21/s379 Confidential information
/us/usc/t21/s379a Presumption of existence of jurisdiction
/us/usc/t21/s379aa Serious adverse event reporting for nonprescription drugs
/us/usc/t21/s379aa-1 Serious adverse event reporting for dietary supplements
/us/usc/t21/s379b Consolidated administrative and laboratory facility
/us/usc/t21/s379dd Establishment and functions of the Foundation
/us/usc/t21/s379d Automation of Food and Drug Administration
/us/usc/t21/s379dd-1 Location of Foundation
/us/usc/t21/s379d-1 Conflicts of interest
/us/usc/t21/s379dd-2 Activities of the Food and Drug Administration
/us/usc/t21/s379d-2 Policy on the review and clearance of scientific articles published by FDA employees
/us/usc/t21/s379d-3 Streamlined hiring authority
/us/usc/t21/s379d-3a Hiring authority for scientific, technical, and professional personnel
/us/usc/t21/s379d-4 Reporting requirements
/us/usc/t21/s379d-5 Guidance document regarding product promotion using the Internet
/us/usc/t21/s379e Listing and certification of color additives for foods, drugs, devices, and cosmetics
/us/usc/t21/s379f Recovery and retention of fees for freedom of information requests
/us/usc/t21/s379g Definitions
/us/usc/t21/s379h Authority to assess and use drug fees
/us/usc/t21/s379h-1 Fees relating to advisory review of prescription-drug television advertising
/us/usc/t21/s379h-2 Reauthorization; reporting requirements
/us/usc/t21/s379i Definitions
/us/usc/t21/s379j Authority to assess and use device fees
/us/usc/t21/s379j-1 Reauthorization; reporting requirements
/us/usc/t21/s379j-11 Definitions
/us/usc/t21/s379j-12 Authority to assess and use animal drug fees
/us/usc/t21/s379j-13 Reauthorization; reporting requirements
/us/usc/t21/s379j-21 Authority to assess and use generic new animal drug fees
/us/usc/t21/s379j-22 Reauthorization; reporting requirements
/us/usc/t21/s379j-31 Authority to collect and use fees
/us/usc/t21/s379j-41 Definitions
/us/usc/t21/s379j-42 Authority to assess and use human generic drug fees
/us/usc/t21/s379j-43 Reauthorization; reporting requirements
/us/usc/t21/s379j-51 Definitions
/us/usc/t21/s379j-52 Authority to assess and use biosimilar biological product fees
/us/usc/t21/s379j-53 Reauthorization; reporting requirements
/us/usc/t21/s379j-61 Definitions
/us/usc/t21/s379j-62 Authority to assess and use outsourcing facility fees
/us/usc/t21/s379j-71 Definitions
/us/usc/t21/s379j-72 Authority to assess and use OTC monograph fees
/us/usc/t21/s379j-73 Reauthorization; reporting requirements
/us/usc/t21/s379k Information system
/us/usc/t21/s379k-1 Electronic format for submissions
/us/usc/t21/s379l Education
/us/usc/t21/s379v Safety report disclaimers
/us/usc/t21/s379o Environmental impact
/us/usc/t21/s379r National uniformity for nonprescription drugs
/us/usc/t21/s379s Preemption for labeling or packaging of cosmetics
/us/usc/t21/s381 Imports and exports
/us/usc/t21/s382 Exports of certain unapproved products
/us/usc/t21/s383 Office of International Relations
/us/usc/t21/s384 Importation of prescription drugs
/us/usc/t21/s384a Foreign supplier verification program
/us/usc/t21/s384b Voluntary qualified importer program
/us/usc/t21/s384c Inspection of foreign food facilities
/us/usc/t21/s384d Accreditation of third-party auditors
/us/usc/t21/s384e Recognition of foreign government inspections
/us/usc/t21/s384f Strengthening FDA and CBP coordination and capacity
/us/usc/t21/s384g Restricting entrance of illicit drugs
/us/usc/t21/s387 Definitions
/us/usc/t21/s387a FDA authority over tobacco products
/us/usc/t21/s387a-1 Final rule
/us/usc/t21/s387b Adulterated tobacco products
/us/usc/t21/s387c Misbranded tobacco products
/us/usc/t21/s387d Submission of health information to the Secretary
/us/usc/t21/s387e Annual registration
/us/usc/t21/s387f General provisions respecting control of tobacco products
/us/usc/t21/s387f-1 Enforcement action plan for advertising and promotion restrictions
/us/usc/t21/s387g Tobacco product standards
/us/usc/t21/s387h Notification and other remedies
/us/usc/t21/s387i Records and reports on tobacco products
/us/usc/t21/s387j Application for review of certain tobacco products
/us/usc/t21/s387k Modified risk tobacco products
/us/usc/t21/s387l Judicial review
/us/usc/t21/s387m Equal treatment of retail outlets
/us/usc/t21/s387n Jurisdiction of and coordination with the Federal Trade Commission
/us/usc/t21/s387o Regulation requirement
/us/usc/t21/s387p Preservation of State and local authority
/us/usc/t21/s387q Tobacco Products Scientific Advisory Committee
/us/usc/t21/s387r Drug products used to treat tobacco dependence
/us/usc/t21/s387s User fees
/us/usc/t21/s387t Labeling, recordkeeping, records inspection
/us/usc/t21/s387u Studies of progress and effectiveness
/us/usc/t21/s391 Separability clause
/us/usc/t21/s392 Exemption of meats and meat food products
/us/usc/t21/s393 Food and Drug Administration
/us/usc/t21/s393a Office of Pediatric Therapeutics
/us/usc/t21/s394 Scientific review groups
/us/usc/t21/s395 Loan repayment program
/us/usc/t21/s396 Practice of medicine
/us/usc/t21/s397 Contracts for expert review
/us/usc/t21/s398 Notices to States regarding imported food
/us/usc/t21/s399 Grants to enhance food safety
/us/usc/t21/s399a Office of the Chief Scientist
/us/usc/t21/s399b Office of Women’s Health
/us/usc/t21/s399c Improving the training of State, local, territorial, and tribal food safety officials
/us/usc/t21/s399d Employee protections
/us/usc/t21/s399e Nanotechnology
/us/usc/t21/s399f Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
/us/usc/t21/s399g Food and Drug Administration Intercenter Institutes
/us/usc/t21/s399h Grants for studying continuous drug manufacturing
/us/usc/t21/s399i Food and Drug Administration Working Capital Fund
/us/usc/t21/s451 Congressional statement of findings
/us/usc/t21/s452 Congressional declaration of policy
/us/usc/t21/s453 Definitions
/us/usc/t21/s454 Federal and State cooperation in development and administration of State poultry product inspection programs
/us/usc/t21/s455 Inspection in official establishments
/us/usc/t21/s456 Operation of premises, facilities and equipment
/us/usc/t21/s457 Labeling and container standards
/us/usc/t21/s458 Prohibited acts
/us/usc/t21/s459 Compliance by all establishments
/us/usc/t21/s460 Miscellaneous activities subject to regulation
/us/usc/t21/s461 Offenses and punishment
/us/usc/t21/s462 Reporting of violations; notice; opportunity to present views
/us/usc/t21/s463 Rules and regulations
/us/usc/t21/s464 Exemptions
/us/usc/t21/s465 Limitations upon entry of poultry products and other materials into official establishments
/us/usc/t21/s466 Imports
/us/usc/t21/s467 Inspection services
/us/usc/t21/s467a Administrative detention; duration; pending judicial proceedings; notification of government authorities; release; removal of official marks
/us/usc/t21/s467b Seizure and condemnation
/us/usc/t21/s467c Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations; United States as plaintiff; subpenas
/us/usc/t21/s467d Administration and enforcement; applicability of penalty provisions; conduct of inquiries; power and jurisdiction of courts
/us/usc/t21/s467e Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
/us/usc/t21/s467f Federal Food, Drug, and Cosmetic Act applications
/us/usc/t21/s468 Cost of inspection; overtime
/us/usc/t21/s469 Authorization of appropriations
/us/usc/t21/s471 Safe Meat and Poultry Inspection Panel
/us/usc/t21/s472 Interstate shipment of poultry inspected by Federal and State agencies for certain small establishments
/us/usc/t21/s473 Grants for improvements to meat and poultry facilities to allow for interstate shipment
/us/usc/t21/s601 Definitions
/us/usc/t21/s602 Congressional statement of findings
/us/usc/t21/s603 Examination of animals prior to slaughter; use of humane methods
/us/usc/t21/s604 Post mortem examination of carcasses and marking or labeling; destruction of carcasses condemned; reinspection
/us/usc/t21/s605 Examination of carcasses brought into slaughtering or packing establishments, and of meat food products issued from and returned thereto; conditions for entry
/us/usc/t21/s606 Inspection and labeling of meat food products
/us/usc/t21/s607 Labeling, marking, and container requirements
/us/usc/t21/s608 Sanitary inspection and regulation of slaughtering and packing establishments; rejection of adulterated meat or meat food products
/us/usc/t21/s609 Examination of animals and food products thereof, slaughtered and prepared during nighttime
/us/usc/t21/s610 Prohibited acts
/us/usc/t21/s611 Devices, marks, labels, and certificates; simulations
/us/usc/t21/s612 Notification
/us/usc/t21/s613 Plans and reassessments
/us/usc/t21/s615 Inspection of carcasses, meat of which is intended for export
/us/usc/t21/s616 Inspectors of carcasses, etc., meat of which is intended for export; certificates of condition
/us/usc/t21/s617 Clearance prohibited to vessel carrying meat for export without inspector’s certificate
/us/usc/t21/s618 Delivery of inspectors’ certificates, and of copies
/us/usc/t21/s619 Marking, labeling, or other identification to show kinds of animals from which derived; separate establishments for preparation and slaughtering activities
/us/usc/t21/s620 Imports
/us/usc/t21/s621 Inspectors to make examinations provided for; appointment; duties; regulations
/us/usc/t21/s622 Bribery of or gifts to inspectors or other officers and acceptance of gifts
/us/usc/t21/s623 Exemptions from inspection requirements
/us/usc/t21/s624 Storage and handling regulations; violations; exemption of establishments subject to non-Federal jurisdiction
/us/usc/t21/s625 Inapplicability of certain requirements to catfish
/us/usc/t21/s626 Purchase of tags, labels, stamps, and certificates
/us/usc/t21/s641 Prohibition of subchapter I inspection of articles not intended for use as human food; denaturation or other identification prior to distribution in commerce; inedible articles
/us/usc/t21/s642 Recordkeeping requirements
/us/usc/t21/s643 Registration of business, name of person, and trade names
/us/usc/t21/s644 Regulation of transactions, transportation, or importation of 4–D animals to prevent use as human food
/us/usc/t21/s645 Federal provisions applicable to State or Territorial business transactions of a local nature and not subject to local authority
/us/usc/t21/s661 Federal and State cooperation
/us/usc/t21/s671 Inspection services; refusal or withdrawal; hearing; business unfitness based upon certain convictions; other provisions for withdrawal of services unaffected; responsible connection with business; finality of Secretary’s actions; judicial review; record
/us/usc/t21/s672 Administrative detention; duration; pending judicial proceedings; notification of governmental authorities; release
/us/usc/t21/s673 Seizure and condemnation
/us/usc/t21/s674 Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations of
/us/usc/t21/s675 Assaulting, resisting, or impeding certain persons; murder; protection of such persons
/us/usc/t21/s676 Violations
/us/usc/t21/s677 Other Federal laws applicable for administration and enforcement of chapter; location of inquiries; jurisdiction of Federal courts
/us/usc/t21/s678 Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
/us/usc/t21/s679 Application of Federal Food, Drug, and Cosmetic Act
/us/usc/t21/s679a Safe Meat and Poultry Inspection Panel
/us/usc/t21/s679b Pasteurization of meat and poultry
/us/usc/t21/s679c Expansion of Food Safety Inspection Service activities
/us/usc/t21/s680 Authorization of appropriations
/us/usc/t21/s683 Interstate shipment of meat inspected by Federal and State agencies for certain small establishments
/us/usc/t21/s692 Inspection extended to reindeer
/us/usc/t21/s693 Inspection of dairy products for export
/us/usc/t21/s694 Authorization of appropriations
/us/usc/t21/s695 Payment of cost of meat-inspection service; exception
/us/usc/t21/s801 Congressional findings and declarations: controlled substances
/us/usc/t21/s801a Congressional findings and declarations: psychotropic substances
/us/usc/t21/s802 Definitions
/us/usc/t21/s811 Authority and criteria for classification of substances
/us/usc/t21/s812 Schedules of controlled substances
/us/usc/t21/s813 Treatment of controlled substance analogues
/us/usc/t21/s814 Removal of exemption of certain drugs
/us/usc/t21/s821 Rules and regulations
/us/usc/t21/s822 Persons required to register
/us/usc/t21/s822a Prescription drug take back expansion
/us/usc/t21/s823 Registration requirements
/us/usc/t21/s824 Denial, revocation, or suspension of registration
/us/usc/t21/s825 Labeling and packaging
/us/usc/t21/s826 Production quotas for controlled substances
/us/usc/t21/s826a Attorney General report on drug shortages
/us/usc/t21/s827 Records and reports of registrants
/us/usc/t21/s828 Order forms
/us/usc/t21/s829 Prescriptions
/us/usc/t21/s829a Delivery of a controlled substance by a pharmacy to an administering practitioner
/us/usc/t21/s830 Regulation of listed chemicals and certain machines
/us/usc/t21/s831 Additional requirements relating to online pharmacies and telemedicine
/us/usc/t21/s832 Suspicious orders
/us/usc/t21/s841 Prohibited acts A
/us/usc/t21/s842 Prohibited acts B
/us/usc/t21/s843 Prohibited acts C
/us/usc/t21/s844 Penalties for simple possession
/us/usc/t21/s844a Civil penalty for possession of small amounts of certain controlled substances
/us/usc/t21/s846 Attempt and conspiracy
/us/usc/t21/s847 Additional penalties
/us/usc/t21/s848 Continuing criminal enterprise
/us/usc/t21/s849 Transportation safety offenses
/us/usc/t21/s850 Information for sentencing
/us/usc/t21/s851 Proceedings to establish prior convictions
/us/usc/t21/s852 Application of treaties and other international agreements
/us/usc/t21/s853 Criminal forfeitures
/us/usc/t21/s854 Investment of illicit drug profits
/us/usc/t21/s855 Alternative fine
/us/usc/t21/s856 Maintaining drug-involved premises
/us/usc/t21/s858 Endangering human life while illegally manufacturing controlled substance
/us/usc/t21/s859 Distribution to persons under age twenty-one
/us/usc/t21/s860 Distribution or manufacturing in or near schools and colleges
/us/usc/t21/s860a Consecutive sentence for manufacturing or distributing, or possessing with intent to manufacture or distribute, methamphetamine on premises where children are present or reside
/us/usc/t21/s861 Employment or use of persons under 18 years of age in drug operations
/us/usc/t21/s862 Denial of Federal benefits to drug traffickers and possessors
/us/usc/t21/s862a Denial of assistance and benefits for certain drug-related convictions
/us/usc/t21/s862b Sanctioning for testing positive for controlled substances
/us/usc/t21/s863 Drug paraphernalia
/us/usc/t21/s864 Anhydrous ammonia
/us/usc/t21/s864a Grants to reduce production of methamphetamines from anhydrous ammonia
/us/usc/t21/s865 Smuggling methamphetamine or methamphetamine precursor chemicals into the United States while using facilitated entry programs
/us/usc/t21/s871 Attorney General
/us/usc/t21/s871a Semiannual reports to Congress
/us/usc/t21/s872 Education and research programs of Attorney General
/us/usc/t21/s872a Public-private education program
/us/usc/t21/s873 Cooperative arrangements
/us/usc/t21/s874 Advisory committees
/us/usc/t21/s875 Administrative hearings
/us/usc/t21/s876 Subpenas
/us/usc/t21/s877 Judicial review
/us/usc/t21/s878 Powers of enforcement personnel
/us/usc/t21/s879 Search warrants
/us/usc/t21/s880 Administrative inspections and warrants
/us/usc/t21/s881 Forfeitures
/us/usc/t21/s882 Injunctions
/us/usc/t21/s883 Enforcement proceedings
/us/usc/t21/s884 Immunity and privilege
/us/usc/t21/s885 Burden of proof; liabilities
/us/usc/t21/s886 Payments and advances
/us/usc/t21/s886a Diversion Control Fee Account
/us/usc/t21/s887 Coordination and consolidation of post-seizure administration
/us/usc/t21/s889 Production control of controlled substances
/us/usc/t21/s890 Review of Federal sales of chemicals usable to manufacture controlled substances
/us/usc/t21/s901 Severability
/us/usc/t21/s902 Savings provisions
/us/usc/t21/s903 Application of State law
/us/usc/t21/s904 Payment of tort claims
/us/usc/t21/s951 Definitions
/us/usc/t21/s952 Importation of controlled substances
/us/usc/t21/s953 Exportation of controlled substances
/us/usc/t21/s954 Transshipment and in-transit shipment of controlled substances
/us/usc/t21/s955 Possession on board vessels, etc., arriving in or departing from United States
/us/usc/t21/s956 Exemption authority
/us/usc/t21/s957 Persons required to register
/us/usc/t21/s958 Registration requirements
/us/usc/t21/s959 Possession, manufacture, or distribution of controlled substance
/us/usc/t21/s960 Prohibited acts A
/us/usc/t21/s960a Foreign terrorist organizations, terrorist persons and groups
/us/usc/t21/s961 Prohibited acts B
/us/usc/t21/s962 Second or subsequent offenses
/us/usc/t21/s963 Attempt and conspiracy
/us/usc/t21/s964 Additional penalties
/us/usc/t21/s965 Applicability of part E of subchapter I
/us/usc/t21/s966 Authority of Secretary of the Treasury
/us/usc/t21/s967 Smuggling of controlled substances; investigations; oaths; subpenas; witnesses; evidence; production of records; territorial limits; fees and mileage of witnesses
/us/usc/t21/s968 Service of subpena; proof of service
/us/usc/t21/s969 Contempt proceedings
/us/usc/t21/s970 Criminal forfeitures
/us/usc/t21/s971 Notification, suspension of shipment, and penalties with respect to importation and exportation of listed chemicals
/us/usc/t21/s1031 Congressional statement of findings
/us/usc/t21/s1032 Congressional declaration of policy
/us/usc/t21/s1033 Definitions
/us/usc/t21/s1034 Inspection of egg products
/us/usc/t21/s1035 Sanitary operating practices in official plants
/us/usc/t21/s1036 Pasteurization and labeling of egg products at official plants
/us/usc/t21/s1037 Prohibited acts
/us/usc/t21/s1038 Cooperation with appropriate State and other governmental agencies; utilization of employees; reimbursement
/us/usc/t21/s1039 Eggs and egg products not intended for use as human food; inspection; denaturing or otherwise identifying
/us/usc/t21/s1040 Recordkeeping requirements; persons required to maintain records; scope of disclosure; access to records
/us/usc/t21/s1041 Enforcement provisions
/us/usc/t21/s1042 Reporting of violation to United States attorney for institution of criminal proceedings; procedure; presentation of views
/us/usc/t21/s1043 Rules and regulations; administration and enforcement
/us/usc/t21/s1044 Exemption of certain activities
/us/usc/t21/s1045 Limitation on entry of eggs and egg products and other materials into official plants
/us/usc/t21/s1046 Imports
/us/usc/t21/s1047 Refusal or withdrawal of inspection services; hearing; grounds; person deemed to have responsible connection with business; finality of order of Secretary; judicial review; other provisions for refusal of services unaffected
/us/usc/t21/s1048 Administrative detention of violative articles; duration; release; removal of official marks
/us/usc/t21/s1049 Seizure and condemnation proceedings
/us/usc/t21/s1050 Jurisdiction of district courts; United States as plaintiff in enforcement and restraining proceedings; subpenas for witnesses
/us/usc/t21/s1051 Other Federal laws applicable for administration and enforcement of chapter; prosecution of inquiries; exercise of jurisdiction
/us/usc/t21/s1052 State or local regulation
/us/usc/t21/s1053 Inspection and administration costs
/us/usc/t21/s1054 Annual report to Congressional committees
/us/usc/t21/s1055 Authorization of appropriations
/us/usc/t21/s1056 Separability
/us/usc/t21/s1101 Congressional findings
/us/usc/t21/s1102 Congressional declaration of national policy
/us/usc/t21/s1115 Notice relating to the control of dangerous drugs
/us/usc/t21/s1171 Drug abuse prevention function appropriations
/us/usc/t21/s1177 Special project grants and contracts
/us/usc/t21/s1178 Records and audit
/us/usc/t21/s1179 National Drug Abuse Training Center
/us/usc/t21/s1181 Contract authority
/us/usc/t21/s1401 Pesticide monitoring and enforcement information
/us/usc/t21/s1402 Foreign pesticide information
/us/usc/t21/s1403 Pesticide analytical methods
/us/usc/t21/s1505a Annual report on development and deployment of narcotics detection technologies
/us/usc/t21/s1521 Findings
/us/usc/t21/s1522 Purposes
/us/usc/t21/s1523 Definitions
/us/usc/t21/s1524 Authorization of appropriations
/us/usc/t21/s1531 Establishment of drug-free communities support program
/us/usc/t21/s1532 Program authorization
/us/usc/t21/s1533 Information collection and dissemination with respect to grant recipients
/us/usc/t21/s1534 Technical assistance and training
/us/usc/t21/s1535 Supplemental grants for coalition mentoring activities
/us/usc/t21/s1536 Community-based coalition enhancement grants to address local drug crises
/us/usc/t21/s1601 Findings
/us/usc/t21/s1602 Definitions
/us/usc/t21/s1603 General requirements; applicability; preemption
/us/usc/t21/s1604 Liability of biomaterials suppliers
/us/usc/t21/s1605 Procedures for dismissal of civil actions against biomaterials suppliers
/us/usc/t21/s1606 Subsequent impleader of dismissed biomaterials supplier
/us/usc/t21/s1701 Definitions
/us/usc/t21/s1702 Office of National Drug Control Policy
/us/usc/t21/s1703 Appointment and duties of Director and Deputy Directors
/us/usc/t21/s1704 Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs
/us/usc/t21/s1705 Development, submission, implementation, and assessment of National Drug Control Strategy
/us/usc/t21/s1706 High Intensity Drug Trafficking Areas Program
/us/usc/t21/s1708 Emerging Threats Committee, plan, and media campaign
/us/usc/t21/s1710 Drug Interdiction Coordinator and Committee
/us/usc/t21/s1710a Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
/us/usc/t21/s1711 Authorization of appropriations
/us/usc/t21/s1713 Authorization of use of environmentally-approved herbicides to eliminate illicit narcotics crops
/us/usc/t21/s1714 Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions
/us/usc/t21/s1715 GAO audit
/us/usc/t21/s1901 Findings and policy
/us/usc/t21/s1902 Purpose
/us/usc/t21/s1903 Public identification of significant foreign narcotics traffickers and required reports
/us/usc/t21/s1904 Blocking assets and prohibiting transactions
/us/usc/t21/s1905 Authorities
/us/usc/t21/s1906 Enforcement
/us/usc/t21/s1907 Definitions
/us/usc/t21/s1908 Judicial Review Commission on Foreign Asset Control
/us/usc/t21/s2001 Designation of United States Anti-Doping Agency
/us/usc/t21/s2002 Records, audit, and report
/us/usc/t21/s2003 Authorization of appropriations
/us/usc/t21/s2011 Definitions
/us/usc/t21/s2012 Establishment of clearinghouse and advisory council
/us/usc/t21/s2013 NMIC requirements and review
/us/usc/t21/s2014 Authorization of appropriations
/us/usc/t21/s2101 Findings
/us/usc/t21/s2102 Ensuring the safety of pet food
/us/usc/t21/s2103 Ensuring efficient and effective communications during a recall
/us/usc/t21/s2104 State and Federal cooperation
/us/usc/t21/s2105 Enhanced aquaculture and seafood inspection
/us/usc/t21/s2106 Consultation regarding genetically engineered seafood products
/us/usc/t21/s2107 Sense of Congress
/us/usc/t21/s2108 Annual report to Congress
/us/usc/t21/s2109 Publication of annual reports
/us/usc/t21/s2110 Rule of construction
/us/usc/t21/s2201 Performance standards
/us/usc/t21/s2202 National Agriculture and Food Defense Strategy
/us/usc/t21/s2203 Food and Agriculture Coordinating Councils
/us/usc/t21/s2204 Building domestic capacity
/us/usc/t21/s2205 Food allergy and anaphylaxis management
/us/usc/t21/s2206 Alcohol-related facilities
/us/usc/t21/s2221 Food emergency response network
/us/usc/t21/s2222 Integrated consortium of laboratory networks
/us/usc/t21/s2223 Enhancing tracking and tracing of food and recordkeeping
/us/usc/t21/s2224 Surveillance
/us/usc/t21/s2225 Decontamination and disposal standards and plans
/us/usc/t21/s2241 Inspection by the Secretary of Commerce
/us/usc/t21/s2242 Foreign offices of the Food and Drug Administration
/us/usc/t21/s2243 Smuggled food
/us/usc/t21/s2251 Jurisdiction; authorities
/us/usc/t21/s2252 Compliance with international agreements
/us/usc/t21/s2301 Sense of Congress
/us/usc/t21/s2302 Definitions
/us/usc/t21/s2311 Identification of foreign opioid traffickers
/us/usc/t21/s2312 Imposition of sanctions
/us/usc/t21/s2313 Description of sanctions
/us/usc/t21/s2314 Waivers
/us/usc/t21/s2315 Procedures for judicial review of classified information
/us/usc/t21/s2316 Briefings on implementation
/us/usc/t21/s2331 Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign opioid traffickers
/us/usc/t21/s2332 Authorization of appropriations
/us/usc/t21/s2333 Regulatory authority
/us/usc/t21/s2334 Termination
/us/usc/t21/s2335 Exception relating to importation of goods
/us/usc/t21/s2401 Definitions
/us/usc/t21/s2402 Major international doping fraud conspiracies
/us/usc/t21/s2403 Criminal penalties and statute of limitations
/us/usc/t21/s2404 Coordination and sharing of information with USADA
As of Dec. 23, 2021